SEC Form 4 · accession 0001193125-26-274256
IRONWOOD PHARMACEUTICALS INC · IRWD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Catherine Moukheibir
Director
Period of report
Jun 16, 2026
Accepted (ET)
Jun 17, 2026 · 4:36 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001446847
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jun 16, 2026 | A | 63,481 | $0.00 | A | 181,425 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.
Remarks
Exhibit 24 - Power of Attorney